Surgery Partners Cash Flow Statement (2014-2025) | SGRY

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	10.80M	8.80M	8.20M	42.90M	42.80M	15.30M	5.60M	23.30M	1.20M	57.70M	29.70M	46.70M	24.30M	28.40M	6.40M	-46.60M	-0.30M	44.90M	25.30M	29.00M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	5.20M	4.10M	4.10M	4.00M	3.70M	4.30M	5.00M	5.40M	4.20M	4.60M	4.40M	4.50M	4.90M	15.10M	7.10M	6.20M	7.60M	6.80M	2.60M	-2.20M
Deferred Taxes (Quarter)	-0.10M	-3.10M	0.90M	11.20M	1.00M	3.90M	7.50M	9.50M	-1.80M	-9.70M	0.70M	9.10M	2.50M	5.10M	2.70M	121.20M	-0.30M	-1.50M	5.10M	13.40M
Gains from Investment Securities (Quarter)		0.40M	-0.40M		0.90M	-0.50M	0.10M	11.00M	4.10M	44.30M	-45.70M	-0.50M	-1.00M	19.50M	2.80M	-19.30M	10.70M	8.60M	-5.90M	-0.10M
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)	50.20M	2.30M	14.90M	19.70M	79.80M	42.10M	29.70M	7.20M	74.50M	52.10M	104.60M	62.60M	40.70M	82.80M	65.20M	111.40M	6.00M	81.30M	83.60M	103.40M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	25.70M	25.20M	25.20M	22.70M	27.40M	28.00M	29.80M	29.60M	33.70M	24.40M	28.90M	31.10M	33.70M	34.80M	50.20M	33.90M	36.30M	40.30M	39.50M	59.90M
Change in Working Capital
Change in Receivables (Quarter)	-3.90M	7.00M	15.30M	13.70M	-2.00M	-3.40M	2.00M	38.70M	-8.80M	13.90M	13.10M	29.00M	-5.40M	17.50M	19.10M	40.90M	-4.80M	-3.70M	16.20M	46.10M
Change in Accured Expenses (Quarter)	-7.20M	-21.60M	-19.70M	-25.10M	-18.00M	-22.20M	-13.50M	-4.70M	-1.20M
Other Working Capital Changes (Quarter)	-1.60M	-3.40M	7.10M	41.30M	-7.20M	7.00M	21.10M	46.10M	-2.60M	15.90M	-34.90M	37.90M	43.10M	4.00M	9.10M	-9.40M	61.70M	20.40M	2.20M	-27.70M
Investing Activities
Capital Expenditures (Quarter)	14.50M	13.50M	15.50M	14.10M	18.20M	22.40M	17.30M	22.70M	24.30M	25.80M	18.90M	19.80M	21.00M	26.90M	20.20M	22.30M	22.70M	23.40M	19.80M	12.80M
Sales of Property, Plant and Equipment (Quarter)	2.30M	0.20M		3.50M				12.90M	8.00M	18.10M	-0.30M		1.50M			1.10M	4.80M	38.10M		3.60M
Acquisitions (Quarter)	2.10M	13.10M	85.80M	184.80M	31.10M	43.80M	64.30M	63.80M	40.70M	2.80M	5.30M	31.20M	54.60M	210.00M	26.60M	87.60M	44.00M	4.00M	4.60M	109.50M
Divestments (Quarter)				5.40M	11.50M			1.30M			1.00M	0.40M				0.60M				1.50M
Cash from Investing Activities (Quarter)	-14.30M	-26.40M	-101.00M	-190.00M	-47.10M	-134.30M	-54.30M	-72.20M	-70.70M	-71.20M	-25.60M	-58.10M	-83.10M	-244.10M	-49.60M	-111.70M	-76.40M	2.10M	-46.20M	-126.10M
Financing Activities
Other financing activities (Quarter)	1.00M	11.70M	-27.10M	-3.50M	0.70M	-0.70M	-6.30M	6.30M	1.30M	0.10M	-0.70M	7.50M	1.40M	-7.10M	-3.40M	-3.50M	1.70M	1.40M	-1.50M	2.50M
Cash from Financing Activities (Quarter)	187.80M	-53.00M	-48.30M	229.80M	-43.70M	-59.30M	-48.00M	193.10M	-41.20M	-49.00M	-20.40M	-44.60M	31.70M	189.60M	-7.30M	48.00M	30.20M	-62.60M	-84.10M	59.20M
Dividend Payments
Dividends Paid - Common (Quarter)	5.10M	58.30M	-58.30M	125.90M	36.20M	39.00M	35.30M	36.30M	41.90M	35.00M	34.10M	35.10M	40.50M	40.20M	41.70M	48.10M	62.30M	54.00M	52.50M	57.20M
Additional items
Change in Cash (Quarter)	223.70M	-77.10M	-134.40M	59.50M	-11.00M	-151.50M	-72.60M	128.10M	-37.40M	-68.10M	58.60M	-40.10M	-10.70M	28.30M	8.30M	47.70M	-40.20M	20.80M	-46.70M	36.50M
Free Cash Flow (Quarter)	35.70M	-11.20M	-0.60M	5.60M	61.60M	19.70M	12.40M	-15.50M	50.20M	26.30M	85.70M	42.80M	19.70M	55.90M	45.00M	89.10M	-16.70M	57.90M	63.80M	90.60M
Net Cash Flow (Quarter)	223.70M	-77.10M	-134.40M	59.50M	-11.00M	-151.50M	-72.60M	128.10M	-37.40M	-68.10M	58.60M	-40.10M	-10.70M	28.30M	8.30M	47.70M	-40.20M	20.80M	-46.70M	36.50M

Research Tools

Surgery Partners Cash Flow Statement (2014-2025) | SGRY

Create an account

Sign In

Reset Password